TTK Healthcare Intrinsic Value
TTKHLTCARE Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹562.80 | ₹450.24 - ₹675.36 | -44.2% | EPS: ₹46.90, Sector P/E: 12x |
| Book Value Method | asset | ₹760.71 | ₹684.64 - ₹836.78 | -24.5% | Book Value/Share: ₹760.71, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹513.71 | ₹462.34 - ₹565.08 | -49.0% | Revenue/Share: ₹642.14, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹407.14 | ₹366.43 - ₹447.85 | -59.6% | EBITDA: ₹95.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹403.20 | ₹322.56 - ₹483.84 | -60.0% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹463.59 | ₹417.23 - ₹509.95 | -54.0% | EPS Growth: 12.4%, Fair P/E: 9.9x |
| Growth Adjusted P/E | growth | ₹393.79 | ₹354.41 - ₹433.17 | -60.9% | Revenue Growth: 9.9%, Adj P/E: 8.4x |
| ROE Based Valuation | profitability | ₹504.00 | ₹453.60 - ₹554.40 | -50.0% | ROE: 6.2%, P/E Multiple: 10x |
| Graham Defensive Method | conservative | ₹895.96 | ₹806.36 - ₹985.56 | -11.1% | EPS: ₹46.90, BVPS: ₹760.71 |
Want to compare with current market value? Check TTKHLTCARE share price latest .
Valuation Comparison Chart
TTKHLTCARE Intrinsic Value Analysis
What is the intrinsic value of TTKHLTCARE?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of TTK Healthcare (TTKHLTCARE) is ₹504.00 (median value). With the current market price of ₹1008.00, this represents a -50.0% variance from our estimated fair value.
The valuation range spans from ₹393.79 to ₹895.96, indicating ₹393.79 - ₹895.96.
Is TTKHLTCARE undervalued or overvalued?
Based on our multi-method analysis, TTK Healthcare (TTKHLTCARE) appears to be trading above calculated value by approximately 50.0%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 220.80 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Debt to Equity Ratio | 1.20 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Return on Equity | 6.2% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 3.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.70x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
Related Pages for TTK Healthcare
Additional stock information and data for TTKHLTCARE
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-4 Cr | ₹-4 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹-5 Cr | ₹-5 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹-25 Cr | ₹-25 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹45 Cr | ₹30 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹96 Cr | ₹58 Cr | Positive Free Cash Flow | 8/10 |